Pills in a bottle/Credit: coffeehuman/Shutterstock.com

The average prices of top-selling drugs used by Medicare enrollees have tripled in cost since coming on the market, a new report from AARP has found. List prices for these drugs have increased by an average of 226%, rising at a considerably higher rate than inflation, and AARP officials said this reflected a general trend in the pharmaceutical industry. The report also points to recently passed legislation that allows Medicare to negotiate drug prices in an effort to moderate rising drug costs for both Medicare enrollees and those in private health plans.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employee-Paid
Employer-Paid